Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06141447

Changes in Hemorrhage With Prophylactic Oxytocin for Dilation and Evacuation

Changes in Rate of Hemorrhage With Prophylactic Oxytocin for Second Trimester Dilation and Evacuation in the Clinic Setting

Status
Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
Female
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to assess the effectiveness of prophylactic oxytocin on hemorrhage rates for second trimester dilation and evacuation (D\&E) in the clinic setting.

Conditions

Interventions

TypeNameDescription
DRUGOxytocin + normal saline40 units IV oxytocin once in a 1000 mL bag of normal saline
DRUGNormal saline1000 mL bag of normal saline alone

Timeline

Start date
2024-05-02
Primary completion
2026-11-02
Completion
2026-11-02
First posted
2023-11-21
Last updated
2024-12-10

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06141447. Inclusion in this directory is not an endorsement.